High-sensitivity C-reactive protein (hs-CRP) is a widely established biomarker of systemic inflammation and a downstream effector of IL-6 signaling, with numerous studies linking it to poor glycemic control and cardiovascular risk in both T1D and T2D [12]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.